Tenofovir alafenamide nephrotoxicity in an HIV-positive patient: A case report

RATIONALE: Tenofovir alafenamide (TAF) is novel prodrug of Tenofovir, a nucleotide reverse transcriptase inhibitor. TAF is less nephrotoxic than its predecessor prodrug, tenofovir disoproxil fumarate (TDF). Tenofovir causes mitochondrial dysfunction and tubular injury when there is elevated accumula...

Descripción completa

Detalles Bibliográficos
Autores principales: Novick, Tessa K., Choi, Michael J., Rosenberg, Avi Z., McMahon, Blaithin A., Fine, Derek, Atta, Mohamed G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393094/
https://www.ncbi.nlm.nih.gov/pubmed/28885375
http://dx.doi.org/10.1097/MD.0000000000008046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393094/
https://www.ncbi.nlm.nih.gov/pubmed/28885375
http://dx.doi.org/10.1097/MD.0000000000008046

Ejemplares similares